AFT
22/12/2015 10:16
LISTING
NOT PRICE SENSITIVE
REL: 1016 HRS AFT Pharmaceuticals Limited
LISTING: AFT: Listing & Quotation Notice: AFT Pharmaceuticals Ltd ("AFT")
LISTING AND QUOTATION NOTICE: NZX MAIN BOARD
AFT PHARMACEUTICALS LIMITED ORDINARY SHARES ("AFT")
Company: AFT Pharmaceuticals Limited
Issuer Code: AFT
ISIN: NZAFTE0001S4
Short Name: AFT
Registered Office: Level 1, 129 Hurstmere Road, Takapuna, Auckland
Website: www.aftpharm.com
Telephone Number: 0800 423 823
Financial Year End: 31 March
Nature of Business: AFT is a growing multinational pharmaceutical company
that develops, markets and distributes a broad portfolio of pharmaceutical
products across a wide range of therapeutic categories which are distributed
across all major pharmaceutical distribution channels: over-the-counter,
prescription and hospital. AFT's product portfolio comprises both
proprietary and in-licensed products, and includes patented, branded and
generic drugs.
Directors: David Flacks (Chairman), Hartley Atkinson, Marree Atkinson, Nathan
Hukill, Jon Lamb, John Douglas Wilson and James Burns
Details of Issue: An Offer of ordinary shares in AFT, comprising both new
Shares to be issued by AFT and existing Shares held by the Selling
Shareholder
The Offer comprises:
o An offer by AFT of $30.2 million of new Shares by AFT (being 10.8 million
new Shares) plus oversubscriptions of up to $4.0 million of new Shares (being
1.4 million new Shares); and
o An offer by the Selling Shareholder of $3.0 million of existing Shares
(being 1.1 million existing Shares following the Share Split)
Quoted Securities at Completion of Offer: 96,834,838
Priority Offer Minimum Subscription Amount: $500
Broker Firm Offer Minimum Subscription Amount: 350 Shares ($980)
Offer Price: $2.80 per share
Tick Size: $0.01
Lead Manager and Arranger: First NZ Capital Securities Limited
Auditors: PricewaterhouseCoopers
Solicitors: Harmos Horton Lusk Limited
Registrar: Computershare Investor Services Limited ("RMLT")
Settlement Status: NZCDC Settlement System
Product Disclosure Statement Dated: 26 November 2015, as replaced 1 December
2015
Offer Opens: 4 December 2015
Priority Offer Closes: 16 December 2015
Broker Firm Offer Closes: 17 December 2015
Allotment Date: 21 December 2015
Mailing of Holder Notices: 21 December 2015
Expected Commencement of Trading on the NZX Main Board: 22 December 2015
Tim Bennett
Chief Executive Officer
NZX Limited
22 December 2015
End CA:00275562 For:AFT Type:LISTING Time:2015-12-22 10:16:55
